.FDA declines experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Authorize MDMA Therapy, Finding Even More Study The Nyc TimesFDA Refuses Ecstasy-Based Drug The Stock market JournalFDA declines to approve unique MDMA therapy to alleviate post-traumatic stress disorder, with request for even more trial data CNNFDA refuses first experimental to handle PTSD, asking for additional research The Washington Article.